Morning-Outlook-Feature-Image

NIFTY:

Nifty touch fresh highs above 18800 levels However, profit  booking on last trading session and closed almost 1 % down at  18812. This week belongs to midcap and small cap space and both  the indices gained 2% as Technology and Financial midcaps took  the limelight. Going ahead, we expect some consolidation in Nifty  and levels near 18400-18500 to provide immediate support to the index.

Sectorally, we believe the ongoing positive bias in mid cap and  small cap space may continue while Nifty may take some breather.  However, we remain positive in technology space which has seen some reversal after significantly underperforming markets in last  one year. Nifty is trading at its one of the lowest volatility post  pandemic. Hence a round of uptick in volatility can not be ruled out which may triggers some profit booking.

BANK NIFTY:

Bank Nifty opened at 42976 with a gap down of 200 points. The  index finds support quickly and again bounced up.Banknifty  recoves form the day low but it was most of dull session with the  index but stock specific movement specially in psu sector kept the  trades busy .

On the option front, 42500 Put whereas 44000 strike Calls are  witnessing major writing . No major out-performance is expected  in the banking stocks and the performance would be inline with

Nifty. However, in the current leg of consolidation, we don’t expect  Bank Nifty to violate 42500 which remains the strong support

TECHNICAL PICKS

COMPANY NAME CMP B/S RATIONALE+
ADANIENT 3922 BUY The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be buy with a  stop loss of 3890 and for the target of 3980.
AMBUJA CEM 580.95 BUY The immediate trend of the script is bullish. There is a positive cross over of moving averages as well as of the indicators  therefore it can be buy above 582 with a stop loss of 577 and target of 596.

DERIVATIVE PICKS

Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
Grasim 1900CE BUY 19 CMP 7 50 OI Increase
Long Buildup
Stocks Price Price% OI % OI
L&TFH.22.12 Dec 92.1 3.31 10.21 60674276
OFSS.22.12 Dec 3244.95 3.02 12.52 625600
BSOFT.22.12 Dec 334.25 2.69 4.68 8112000
MANAPPURAM.22.12

Dec

120.25 2.43 2.27 36744000
UBL.22.12 Dec 1749.65 2.12 25.06 1183600
Short Covering
BHEL.22.12 Dec 91.5 7.46 -11.01 95434500
ASTRAL.22.12 Dec 2034.7 4.85 -5.23 1356025
M&MFIN.22.12 Dec 229.85 3.75 -0.7 18204000
POLYCAB.22.12 Dec 2696.15 3.03 -6.97 1053900
lLiTteTSW.2e2a.l1t2hDeLctd. – S-8,DD A Sh4o2p9p6i.n2g Comple2x.,9M9 ay ur Viha-1r-01.1, 8Ne w De8l2h7i8-01010

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Sbi Cards And Payment Se 838.35 0.47 1007514 452775 81.58 Nifty50 18696.1 -0.62 31669085
Coalindia 226.6 0.22 6325649 3294569 74.84 Nifty100 18870.25 -0.54 15214990
Power Grid Corporation o 219.8 -0.95 9660712 6395243 74.46 Niftybank 43103.75 -0.36 13770363
Hdfc Asset Management Co 2193.95 -0.27 358759 223423 74.14 Nifty it 31052.1 -0.22 1314851
Icici Lombard General In 1238.65 1.15 864356 476520 73.99 Nifty Midcap 50 8994.15 0.69 7020303
Ipca Laboratories Ltd. 868.55 0.45 307444 185450 72.34 Nifty Midcap 100 32566.85 0.88 3920869
Itc Ltd. 337.15 -0.71 8388835 5530292 72.01 India Vix 13.45 0.67 4.37E+08
Oil & Natural Gas Corp 140.9 0.61 24518337 8090338 71.9 Nifty Energy 27028.05 -0.57 1093406
Oracle Fin Serv Soft Ltd 3218.8 3.1 539699 120898 71.61 Nifty Fmcg 45154.2 -0.48 694369
Hdfc Bank Ltd. 1607.1 -0.77 3905539 2675200 70.55 Nifty Mnc 20394.45 -0.28 2075891

UPCOMING ECONOMIC DATA

Domestic  International
INR: RBI MPC Meeting Minutes on 5th December, 2022  INR: Interest Rate Decision on 7th December, 2022 USD: ISM Non-Manufacturing PMI (Nov) on 5th December, 2022  USD: Crude Oil Inventories on 7th December, 2022

NEWS UPDATES

  • Indian benchmark indices broke eight-day gaining momentum and ended lower with Nifty around 18,700.At Close, the Sensex was down 415.69 points or 0.66% at 62,868.50, and the Nifty was down 116.40 points or 0.62% at 18,696.10. About 1995 shares have advanced, 1376 shares declined, and 137 shares are unchanged.

 

  • After a healthy subscription, investors who bid for Uniparts India’s initial public offering (IPO)will be closely tracking the share allotment and listing dates.Opened on November 30, the Rs 836-crore public issue closed on December 2 and was subscribed more than 25 times, supported by all categories of investors

 

  • Ambit Asset Management CEO Sushant Bhansali thinks that the Indian market, which has been scaling new highs, shrugging off weak global cues, has already priced in rate hikes by the Reserve Bank of India and the US Federal Reserve

 

  • The S&P 500 closed slightly lower on Friday, although major indexes rallied off their worst levels of the day, as the November payrolls report fueled expectations the Federal Reserve would maintain its path of interest rate hikes to combat inflation.

 

Source: Economic Times, Indian Express, Business Today, Livemint, Business Standard, Bloomberg Quint

BOARD MEETINGS

Company Name Purpose MeetinDate Company Name Purpose MeetinDate
ALFATRAN Issue Of Warrants;Preferential Issue of shares 05-Dec-22 WARDINMOBI General 06-Dec-22
BHANDERI Quarterly Results 05-Dec-22 ACEMEN Right Issue of Equity Shares;Increase in Authorised Capital;Preferential Issue of shares;A.G.M.;General 07-Dec-22
DHANBANK General 05-Dec-22 BRFL Quarterly Results 07-Dec-22
GUJTLRM Preferential Issue of shares 05-Dec-22 CENTEXT General 07-Dec-22
MARG Quarterly Results 05-Dec-22 DECCAN General 07-Dec-22
MTPL General 05-Dec-22 FRSHTRP Buy Back of Shares 07-Dec-22
MUFIN General 05-Dec-22 LUMAXIND General 07-Dec-22
RAJINFRA General 05-Dec-22 RLFL General 07-Dec-22
SABTN General 05-Dec-22 SHAWGELTIN Interim Dividend 07-Dec-22
SOFTRAKV General 05-Dec-22 TAKE Quarterly Results 07-Dec-22
SUKHJITS Interim Dividend 05-Dec-22 CAPFIN General 08-Dec-22
TIGERLOGS General 05-Dec-22 MFSINTRCRP Quarterly Results 08-Dec-22
TRIVIKRAMA General 05-Dec-22 YASHINNO Scheme of Arrangement 08-Dec-22
VEERHEALTH Preferential Issue of shares;General 05-Dec-22 ARISE General 09-Dec-22
ARYAN General 06-Dec-22 KCLINFRA Right Issue of Equity Shares;Rights Issue 09-Dec-22
BIKAJI Quarterly Results;General 06-Dec-22 SCC General 09-Dec-22
GRAUWEIL General 06-Dec-22 VGUARD General 09-Dec-22
INTECH General 06-Dec-22 VLL General 09-Dec-22
LELAVOIR General 06-Dec-22 AGARWAL General 10-Dec-22
MAGANTR General 06-Dec-22 QGO General 10-Dec-22
MARKOLINES Right Issue of Equity Shares 06-Dec-22 AKASHDEEP Stock Split 12-Dec-22
MAXHEIGHTS Stock Split;General 06-Dec-22 ESHAMEDIA A.G.M. 12-Dec-22
PHARMAID General 06-Dec-22 SHREESEC Stock Split 16-Dec-22
PTC Quarterly Results 06-Dec-22 PIFL General 21-Dec-22
STARHFL General 06-Dec-22 COFORGE Interim Dividend;Quarterly Results 20-Jan-23

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
PANCHSHEEL 05-Dec-22 Interim Dividend – Rs. – 0.8000 VALENCIA 12-Dec-22 E.G.M.
TRIVENIGQ 06-Dec-22 E.G.M. COSMOFIRST 13-Dec-22 Buy Back of Shares
ADVAIT 07-Dec-22 E.G.M. TELESYS 14-Dec-22 E.G.M.
HGS 07-Dec-22 Interim Dividend – Rs. – 5.0000 BAROEXT 15-Dec-22 E.G.M.
ALKALI 08-Dec-22 E.G.M. RCF 15-Dec-22 Final Dividend – Rs. – 2.5000
APTUS 08-Dec-22 Interim Dividend – Rs. – 2.0000 RCF 15-Dec-22 Interim Dividend – Rs. – 1.6000
BLS 08-Dec-22 Bonus issue 1:1 GLOSTERLTD 16-Dec-22 Bonus issue 1:1
CANFINHOME 08-Dec-22 Interim Dividend – Rs. – 1.5000 PRECWIRE 22-Dec-22 Bonus issue 1:2

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL